Dicerna Pharmaceuticals (DRNA) Short Interest Ratio & Short Volume → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free DRNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Dicerna Pharmaceuticals Short Interest DataCurrent Short Volume4,770,000 sharesPrevious Short Volume4,360,000 sharesChange Vs. Previous Month+9.40%Dollar Volume Sold Short$181.50 millionShort Interest Ratio / Days to Cover1.8Last Record DateDecember 15, 2021Outstanding Shares78,129,000 sharesFloat Size68,220,000 sharesShort Percent of Float6.99%Today's Trading Volume0 sharesAverage Trading Volume1,344,033 sharesToday's Volume Vs. Average0% Short Selling Dicerna Pharmaceuticals ? Sign up to receive the latest short interest report for Dicerna Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDRNA Short Interest Over TimeDRNA Days to Cover Over TimeDRNA Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Dicerna Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/20214,770,000 shares $181.50 million +9.4%7.0%1.8 $38.05 11/30/20214,360,000 shares $165.72 million +51.4%6.4%2 $38.01 11/15/20212,880,000 shares $61.03 million -32.4%4.2%1.8 $21.19 10/29/20214,260,000 shares $88.65 million -1.8%6.2%4.8 $20.81 10/15/20214,340,000 shares $92.14 million -10.5%6.4%4.5 $21.23 9/30/20214,850,000 shares $97.78 million +17.4%7.1%4.8 $20.16 Get the Latest News and Ratings for DRNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dicerna Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/15/20214,130,000 shares $87.60 million +0.2%6.1%4 $21.21 8/31/20214,120,000 shares $84.79 million -19.4%6.1%4.1 $20.58 8/13/20215,110,000 shares $105.16 million +9.9%7.5%5.5 $20.58 7/30/20214,650,000 shares $174.42 million -2.1%6.8%5.4 $37.51 7/15/20214,750,000 shares $174.90 million +19.1%7.0%6.6 $36.82 6/30/20213,990,000 shares $148.91 million -19.4%5.9%5.5 $37.32 6/15/20214,950,000 shares $176.91 million -2.6%7.3%6.9 $35.74 5/28/20215,080,000 shares $165.61 million -8.5%7.5%7.2 $32.60 5/14/20215,550,000 shares $139.36 million -3.0%8.2%7 $25.11 4/30/20215,720,000 shares $177.72 million +2.7%8.4%7.3 $31.07 4/15/20215,570,000 shares $155.01 million +4.5%N/A0 $27.83 3/31/20215,330,000 shares $128.56 million +3.3%7.9%6.4 $24.12 3/15/20215,160,000 shares $143.45 million +3.8%7.7%6.3 $27.80 2/26/20214,970,000 shares $140.70 million +7.6%7.4%6.1 $28.31 2/12/20214,620,000 shares $121.00 million -4.7%7.0%6.4 $26.19 1/29/20214,850,000 shares $111.50 million -0.2%7.3%6.9 $22.99 1/15/20214,860,000 shares $118.34 million -6.7%7.3%7 $24.35 12/31/20205,210,000 shares $116.39 million -12.0%7.9%8.3 $22.34 12/15/20205,920,000 shares $146.28 million +1.9%9.0%9.8 $24.71 11/30/20205,810,000 shares $142.58 million +0.7%8.9%10.1 $24.54 11/15/20205,770,000 shares $132.02 million -0.4%8.8%9.9 $22.88 10/30/20205,790,000 shares $123.91 million +24.0%8.9%10 $21.40 10/15/20204,670,000 shares $90.60 million -1.7%7.2%8 $19.40 9/30/20204,750,000 shares $85.45 million +22.4%N/A8.2 $17.99 9/15/20203,880,000 shares $69.88 million -1.8%6.0%6 $18.01 8/31/20203,950,000 shares $73.15 million -1.0%6.1%5.9 $18.52 8/14/20203,990,000 shares $75.81 million +1.8%6.2%6.1 $19.00 7/31/20203,920,000 shares $84.28 million -8.0%6.1%5.7 $21.50 7/15/20204,260,000 shares $99.47 million -1.4%6.6%6.3 $23.35 6/30/20204,320,000 shares $106.79 million +46.0%6.7%6.4 $24.72 6/15/20202,960,000 shares $63.97 million -7.8%4.6%4.6 $21.61 5/29/20203,210,000 shares $69.24 million -5.0%5.0%4.8 $21.57 5/15/20203,380,000 shares $73.24 million +11.2%5.5%4.9 $21.67 4/30/20203,040,000 shares $59.89 million -15.6%4.9%4.5 $19.70SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. DRNA Short Interest - Frequently Asked Questions What is Dicerna Pharmaceuticals' current short interest? Short interest is the volume of Dicerna Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of December 15th, traders have sold 4,770,000 shares of DRNA short. 6.99% of Dicerna Pharmaceuticals' shares are currently sold short. Learn More on Dicerna Pharmaceuticals' current short interest. What is a good short interest ratio for Dicerna Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DRNA shares currently have a short interest ratio of 2.0. Learn More on Dicerna Pharmaceuticals's short interest ratio. What is a good short interest percentage for Dicerna Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.99% of Dicerna Pharmaceuticals' floating shares are currently sold short. Is Dicerna Pharmaceuticals' short interest increasing or decreasing? Dicerna Pharmaceuticals saw a increase in short interest in the month of December. As of December 15th, there was short interest totaling 4,770,000 shares, an increase of 9.4% from the previous total of 4,360,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Dicerna Pharmaceuticals' float size? Dicerna Pharmaceuticals currently has issued a total of 78,129,000 shares. Some of Dicerna Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Dicerna Pharmaceuticals currently has a public float of 68,220,000 shares. How does Dicerna Pharmaceuticals' short interest compare to its competitors? 6.99% of Dicerna Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Dicerna Pharmaceuticals: Arrowhead Pharmaceuticals, Inc. (7.16%), HUTCHMED (China) Limited (0.29%), IDEAYA Biosciences, Inc. (14.29%), Amicus Therapeutics, Inc. (11.00%), Xenon Pharmaceuticals Inc. (3.66%), ACADIA Pharmaceuticals Inc. (6.80%), MoonLake Immunotherapeutics (16.21%), Bausch Health Companies Inc. (6.31%), Axsome Therapeutics, Inc. (16.15%), MorphoSys AG (1.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($10.20 billion), S&P Global Inc. ($9.27 billion), Canadian Pacific Kansas City Limited ($8.89 billion), Charter Communications, Inc. ($4.91 billion), Palo Alto Networks, Inc. ($3.82 billion), Wayfair Inc. ($3.47 billion), Lucid Group, Inc. ($3.06 billion), Zscaler, Inc. ($2.54 billion), Teladoc Health, Inc. ($2.27 billion), and Datadog, Inc. ($2.24 billion). View all of the most shorted stocks. What does it mean to sell short Dicerna Pharmaceuticals stock? Short selling DRNA is an investing strategy that aims to generate trading profit from Dicerna Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dicerna Pharmaceuticals? A short squeeze for Dicerna Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DRNA, which in turn drives the price of the stock up even further. How often is Dicerna Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DRNA, twice per month. The most recent reporting period available is December, 15 2021. More Short Interest Resources from MarketBeat Related Companies: ARWR Short Interest Data HCM Short Interest Data IDYA Short Interest Data FOLD Short Interest Data XENE Short Interest Data ACAD Short Interest Data MLTX Short Interest Data BHC Short Interest Data AXSM Short Interest Data MOR Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DRNA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends